(Q45756207)

English

Clinical and molecular virological differences between fulminant hepatic failures following acute and chronic infection with hepatitis B virus

scientific article published in May 1998

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/9580884

Clinical and molecular virological differences between fulminant hepatic failures following acute and chronic infection with hepatitis B virus (English)

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/9580884

0 references

acute liver failure

0 references

Hepatitis B virus

1 reference

based on heuristic

inferred from title

Hiroaki Okamoto

4

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/9580884

author name string

Inoue K

1

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/9580884

Yoshiba M

2

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/9580884

Sekiyama K

3

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/9580884

Mayumi M

5

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/9580884

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 May 1998

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/9580884

Journal of Medical Virology

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/9580884

55

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/9580884

1

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/9580884

35-41

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/9580884

Multivariate analysis of prognostic factors in fulminant hepatitis B.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199805%2955%3A1%3C35%3A%3AAID-JMV7%3E3.0.CO%3B2-P

21 January 2018

Wild-type and e antigen-minus hepatitis B viruses and course of chronic hepatitis.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199805%2955%3A1%3C35%3A%3AAID-JMV7%3E3.0.CO%3B2-P

21 January 2018

Mutation preventing formation of hepatitis B e antigen in patients with chronic hepatitis B infection.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199805%2955%3A1%3C35%3A%3AAID-JMV7%3E3.0.CO%3B2-P

21 January 2018

The incidence of fulminant hepatic failure in acute viral hepatitis in Taiwan: increased risk in patients with pre-existing HBsAg carrier state

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199805%2955%3A1%3C35%3A%3AAID-JMV7%3E3.0.CO%3B2-P

21 January 2018

Hepatitis B virus DNA in fulminant hepatitis B.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199805%2955%3A1%3C35%3A%3AAID-JMV7%3E3.0.CO%3B2-P

21 January 2018

Targeting of the hepatitis B virus precore protein to the endoplasmic reticulum membrane: after signal peptide cleavage translocation can be aborted and the product released into the cytoplasm

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199805%2955%3A1%3C35%3A%3AAID-JMV7%3E3.0.CO%3B2-P

21 January 2018

Host defenses and immunologic alterations associated with chronic hemodialysis

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199805%2955%3A1%3C35%3A%3AAID-JMV7%3E3.0.CO%3B2-P

21 January 2018

Correlation between anti-HBc titers and HBV DNA in blood units without detectable HBsAg

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199805%2955%3A1%3C35%3A%3AAID-JMV7%3E3.0.CO%3B2-P

21 January 2018

Fulminant hepatitis B: induction by hepatitis B virus mutants defective in the precore region and incapable of encoding e antigen

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199805%2955%3A1%3C35%3A%3AAID-JMV7%3E3.0.CO%3B2-P

21 January 2018

Hepatitis B virus core promoter sequence analysis in fulminant and chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199805%2955%3A1%3C35%3A%3AAID-JMV7%3E3.0.CO%3B2-P

21 January 2018

A hepatitis B virus mutant associated with an epidemic of fulminant hepatitis

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199805%2955%3A1%3C35%3A%3AAID-JMV7%3E3.0.CO%3B2-P

21 January 2018

Multiple liver-specific factors bind to the hepatitis B virus core/pregenomic promoter: trans-activation and repression by CCAAT/enhancer binding protein

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199805%2955%3A1%3C35%3A%3AAID-JMV7%3E3.0.CO%3B2-P

21 January 2018

Serologic markers with fulminant hepatitis in persons positive for hepatitis B surface antigen. A worldwide epidemiologic and clinical survey

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199805%2955%3A1%3C35%3A%3AAID-JMV7%3E3.0.CO%3B2-P

21 January 2018

Hepatitis B virus strains with mutations in the core promoter in patients with fulminant hepatitis

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199805%2955%3A1%3C35%3A%3AAID-JMV7%3E3.0.CO%3B2-P

21 January 2018

Hepatitis B antigen (HBSAg) and/or antibodies (anti-HBS and anti-HBC) in fulminant hepatitis: pathogenic and prognostic significance

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199805%2955%3A1%3C35%3A%3AAID-JMV7%3E3.0.CO%3B2-P

21 January 2018

Enhanced HBsAb production in pathogenesis of fulminant viral hepatitis type B

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199805%2955%3A1%3C35%3A%3AAID-JMV7%3E3.0.CO%3B2-P

21 January 2018

Formation of transmembraneous hepatitis B e-antigen by cotranslational in vitro processing of the viral precore protein

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199805%2955%3A1%3C35%3A%3AAID-JMV7%3E3.0.CO%3B2-P

21 January 2018

Reactivation of chronic type B hepatitis presenting as acute viral hepatitis

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199805%2955%3A1%3C35%3A%3AAID-JMV7%3E3.0.CO%3B2-P

21 January 2018

Nucleotide sequence analysis of the precore region in patients with fulminant hepatitis B in the United States

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199805%2955%3A1%3C35%3A%3AAID-JMV7%3E3.0.CO%3B2-P

21 January 2018

Household bleach as disinfectant for use by injecting drug users

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199805%2955%3A1%3C35%3A%3AAID-JMV7%3E3.0.CO%3B2-P

21 January 2018

Aetiology and prognosis of fulminant viral hepatitis in Japan: a multicentre study. The Study Group of Fulminant Hepatitis

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199805%2955%3A1%3C35%3A%3AAID-JMV7%3E3.0.CO%3B2-P

21 January 2018

Fulminant hepatitis in asymptomatic hepatitis B surface antigen carriers in Greece

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199805%2955%3A1%3C35%3A%3AAID-JMV7%3E3.0.CO%3B2-P

21 January 2018

Development of reliable artificial liver support (ALS)--plasma exchange in combination with hemodiafiltration using high-performance membranes

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199805%2955%3A1%3C35%3A%3AAID-JMV7%3E3.0.CO%3B2-P

21 January 2018

Identifiers

10.1002/(SICI)1096-9071(199805)55:1<35::AID-JMV7>3.0.CO;2-P

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/9580884

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/9580884

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45756207&oldid=2081050922"